3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan and Breast Neoplasms

3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Almendro, V; Carranza, A; Coveñas, R; Garcia-Recio, S; González-Ortega, A; Muñoz, M; Salinas-Martín, MV	1

Other Studies

1 other study(ies) available for 3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan and Breast Neoplasms

Article	Year
The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer. International journal of oncology, 2014, Volume: 45, Issue:4 Topics: Antineoplastic Agents; Aprepitant; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; MCF-7 Cells; Morpholines; Neurokinin-1 Receptor Antagonists; Piperidines; Receptors, Neurokinin-1; Substance P; Tryptophan	2014

Article

Year

The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer.

International journal of oncology, 2014, Volume: 45, Issue:4

Topics: Antineoplastic Agents; Aprepitant; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; MCF-7 Cells; Morpholines; Neurokinin-1 Receptor Antagonists; Piperidines; Receptors, Neurokinin-1; Substance P; Tryptophan

2014